Also known as: Bremelanotide
PT-141, also known as Bremelanotide, is a synthetic peptide that functions as a melanocortin receptor agonist. Classified under the category of Endocrine & Reproductive Peptides, PT-141 is primarily researched for its effects on sexual function and arousal. Originally developed for the treatment of sexual dysfunction, it has garnered attention for its potential applications in various areas of sexual health.
PT-141 operates by activating melanocortin receptors in the brain, specifically the MC3R and MC4R receptors. This activation influences the central nervous system, leading to increased sexual desire and arousal. Unlike traditional treatments that target vascular mechanisms, PT-141's mode of action is neurogenic, making it a unique option in the realm of sexual health therapies.
PT-141 is a promising peptide in the field of sexual health, primarily functioning as a melanocortin receptor agonist. Its unique mechanism of action and potential applications make it a significant subject of research in addressing sexual dysfunction and related conditions.
Last updated: Jan 8, 2026